Tuberculous osteomyelitis

Tuberculous osteomyelitis of the jaws is a rare manifestation of extrapulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis infection of the maxillofacial skeleton.[1][2] The condition arises through hematogenous dissemination from a distant (usually pulmonary) focus or, less commonly, through direct inoculation of the oral mucosa via a breach in the mucosal barrier.[3][4] Jaw involvement accounts for a small fraction of all oral and maxillofacial TB cases, which themselves represent only 0.1%–5% of individuals with TB disease.[1] The characteristic imaging pattern is an ill-defined osteolytic lesion with bone destruction, often mimicking malignancy or pyogenic osteomyelitis.[1][2] Definitive diagnosis requires histopathologic and microbiologic confirmation, and management centers on standard anti-tubercular chemotherapy.[1][5]

The accepted term is tuberculous osteomyelitis (of the jaw). Synonyms in clinical use include tubercular osteomyelitis, osseous tuberculosis of the jaw, and maxillofacial tubercular osteomyelitis.[2] The broader category oral and maxillofacial tuberculosis (OMTB) encompasses both soft-tissue and intraosseous manifestations.[1] When the temporomandibular joint is the primary site, the term tuberculous arthritis of the TMJ may be applied. The condition should be distinguished from pyogenic osteomyelitis and from other granulomatous infections of the jaw (e.g., actinomycotic osteomyelitis).[6][7]

• Sex and age: OMTB shows a male predominance with a male-to-female ratio of approximately 1.7:1 and a mean age of approximately 40 years; the fifth and sixth decades are most commonly affected. Maxillofacial tubercular osteomyelitis specifically may present in younger patients, including children and young adults.[1][2]
• Frequency: Oral and maxillofacial involvement occurs in only 0.1%–5% of all TB patients. Among OMTB cases, intraosseous lesions account for roughly one-quarter.[1]
• Anatomic distribution: The mandible is the most commonly affected jaw bone, representing the majority of intraosseous cases, followed by the dental alveolus, maxilla, and temporomandibular joint.[1]
• Risk factors: HIV co-infection is the strongest risk factor for TB overall; other predisposing conditions include immunosuppression (corticosteroids, TNF-α inhibitors), poorly controlled diabetes, chronic renal failure, tobacco use, and social vulnerability. Mucosal breaks from tooth extraction, trauma, or poor oral hygiene may facilitate primary inoculation.[1][3]

Presentation and symptoms

The clinical presentation is nonspecific and frequently mimics malignancy or other chronic infections.[1][8] Common findings include:

• Swelling: Firm, progressive, often painless or mildly tender swelling of the affected jaw region[1][2]
• Pain and tenderness: Present in the majority of symptomatic patients; approximately one-quarter of OMTB patients are asymptomatic[1]
• Ulceration: Overlying mucosal or cutaneous ulceration, sometimes with draining sinuses[1][2]
• Trismus: Occasionally present, particularly with posterior mandibular or TMJ involvement[2]

Tempo and complications

The clinical course is characteristically chronic and indolent, with symptoms persisting for weeks to months before diagnosis.[6][9] Complications include pathologic fracture, fistula formation, and regional lymphadenopathy. Cervical lymph node enlargement may accompany primary oral TB lesions.[3]

Diagnostic pitfall

TB was the initial clinical diagnostic hypothesis in only approximately 11% of OMTB cases; malignancy—particularly squamous cell carcinoma—was the leading clinical suspicion in nearly half of cases.[1] This underscores the importance of maintaining a high index of suspicion, especially in endemic regions and immunocompromised patients.

Location and distribution

Tuberculous osteomyelitis most commonly involves the body and angle of the mandible.[1][2] Maxillary involvement is less frequent. Lesions may be solitary or, occasionally, multifocal. The alveolar process and the region surrounding the inferior alveolar canal are commonly affected sites.[1]

Periphery and shape

Lesions typically present as ill-defined, irregularly marginated radiolucencies without a sclerotic border.[1][2] The margins are ragged and blend imperceptibly into surrounding bone, reflecting the chronic destructive nature of the granulomatous process. A well-defined lytic appearance has been described occasionally, particularly in calvarial TB, but is uncommon in the jaws.[9]

Internal architecture

• The dominant pattern is osteolysis with bone destruction, which is the most frequently described radiographic finding[1]
• The internal structure is characteristically radiolucent without internal septation or mineralization
• Occasional reports describe mixed radiolucent-radiopaque patterns with foci of shaped radiopacities or calcification, but these are rare[1]
• Sequestrum formation may occur, as in other forms of chronic osteomyelitis, though it is less prominent than in pyogenic osteomyelitis[6][10]

Effects on teeth and adjacent structures

• Alveolar bone resorption and rarefaction around teeth are common findings[1]
• Root resorption of involved teeth has been described but is not a consistent feature
• Widening of the periodontal ligament space and loss of the lamina dura may be seen in the affected region
• Tooth displacement or loosening can occur secondary to progressive bone destruction

Cortical involvement and extent

• Cortical breach is a common finding, with erosion or perforation of the buccal or lingual cortex[2]
• Periosteal reaction (periosteal new bone formation) is characteristic and may appear as a laminated or irregular pattern along the outer cortex[2][11]
• Cortical expansion is occasionally observed[1]
• Erosion of the inferior border of the mandible and condylar resorption have been described[1]
• CBCT provides superior delineation of cortical integrity, periosteal reaction, and the three-dimensional extent of osteolysis compared with panoramic radiography[2][11]

Growth pattern

The lesion tends to spread along the medullary cavity with progressive cortical destruction, reflecting the slow granulomatous process. Soft-tissue extension with abscess formation is common.[2][4] The pattern of bone destruction is predominantly lytic and permeative rather than geographic.

Recognized variants

• TMJ involvement: Presents with condylar erosion, joint space narrowing, and periarticular destruction; may mimic inflammatory arthritis[1]
• Alveolar form: Manifests as localized alveolar bone loss mimicking aggressive periodontitis or a periapical pathology
• Multifocal disease: Rare in the jaws but should prompt evaluation for disseminated TB

CT findings

Medical CT demonstrates the extent of osteolysis, cortical destruction, and associated soft-tissue abnormalities more clearly than conventional radiography.[4][10] Characteristic findings include:

• Irregular osteolytic areas with cortical breach and periosteal reaction
• Soft-tissue abscess formation adjacent to the destroyed bone, which may contain calcifications in chronic cases[4]
• CT is superior for identifying sequestra within areas of bone destruction[10]

MRI findings

MRI is the modality of choice for evaluating marrow involvement and soft-tissue extent:[4][12][13]

• Affected bone marrow shows low signal on T1-weighted and variable to high signal on T2-weighted images, reflecting marrow edema and granulomatous infiltration[13]
• An osseous lesion with intermediate to low signal intensity on T2-weighted images with an associated soft-tissue abscess may be suggestive of tuberculous rather than pyogenic osteomyelitis[13]
• Soft-tissue abscesses and surrounding edema are well delineated on contrast-enhanced sequences
• MRI is particularly valuable for assessing TMJ involvement and intracranial extension

Nuclear medicine

Bone scintigraphy with technetium-99m MDP shows increased uptake at the site of active infection and is highly sensitive for early detection, though it lacks specificity.[10] FDG-PET may demonstrate increased metabolic activity in affected bone and can help assess disease activity.[14]

Tuberculous osteomyelitis of the jaw produces nonspecific imaging findings that overlap substantially with other destructive jaw lesions. The ill-defined osteolysis, cortical breach, and periosteal reaction are shared by several infectious, neoplastic, and histiocytic entities. Clinical context—including endemic exposure, immunosuppression, and chronicity—is essential for narrowing the differential.

The highest-risk diagnostic pitfall is misdiagnosis as malignancy, which occurred in nearly half of reported OMTB cases and can lead to unnecessary radical surgery.[1] Incisional biopsy with tissue submitted for histopathology, acid-fast staining, mycobacterial culture, and nucleic acid amplification testing (e.g., Xpert MTB/RIF) is essential for any persistent, unexplained destructive jaw lesion, particularly in patients from endemic regions.[2][19]

Microscopic findings

The hallmark histopathologic feature is caseating granulomatous inflammation:[1]

• Granulomas composed of epithelioid histiocytes, often with central caseous necrosis, are the most frequently described finding
• Multinucleated giant cells of the Langhans type are characteristic, present in the majority of cases[1]
• Chronic inflammatory infiltrate with lymphocytes and plasma cells surrounds the granulomas[1]
• Non-caseating granulomas may also occur and can complicate differentiation from sarcoidosis or foreign-body reactions[1][8]

Microbiologic confirmation

• Ziehl-Neelsen staining for acid-fast bacilli (AFB) has low sensitivity in paucibacillary jaw lesions and is often inconclusive[2]
• Mycobacterial culture (Löwenstein-Jensen or liquid media) remains the reference standard but requires prolonged incubation (up to 8 weeks) and has moderate sensitivity[2][19]
• Nucleic acid amplification tests (NAATs), particularly Xpert MTB/RIF and Xpert Ultra, offer rapid diagnosis with high sensitivity and specificity for osteoarticular TB and are endorsed by the WHO for extrapulmonary specimens. Xpert Ultra has demonstrated sensitivity exceeding 90% for osteoarticular TB[2][20][21]

Radiologic-pathologic correlation

The osteolytic, destructive radiographic pattern corresponds to areas of caseating granulomatous replacement of normal marrow and trabecular bone. Periosteal reaction reflects the chronic inflammatory stimulus on the periosteum. The absence of significant sclerosis in many cases correlates with the predominantly destructive, caseous nature of the granulomatous process rather than the reactive new bone formation seen in chronic pyogenic osteomyelitis.[4][6]

Workup and referral

• Chest radiography or CT should be obtained to evaluate for concurrent pulmonary TB, which is present in the majority of patients with secondary oral TB[3]
• Tuberculin skin testing (TST) or interferon-gamma release assay (IGRA) should be performed; IGRAs have higher specificity, particularly in BCG-vaccinated populations[22][23]
• Incisional biopsy of the jaw lesion with tissue sent for histopathology, AFB smear, mycobacterial culture, and NAAT (preferably Xpert MTB/RIF Ultra) is the diagnostic standard[2][19]
• Referral to infectious disease is recommended for treatment initiation and monitoring

Definitive treatment

Standard anti-tubercular chemotherapy is the cornerstone of treatment:[1][5]

• Intensive phase (2 months): Isoniazid, rifampin, pyrazinamide, and ethambutol
• Continuation phase: Isoniazid and rifampin
• The ATS/CDC/IDSA guidelines recommend 6- to 9-month rifampin-containing regimens for bone and joint TB; some experts favor 9 months given the difficulty in assessing treatment response[5]
• Daily dosing is preferred for extrapulmonary TB[5]

Role of surgery

Surgical intervention is generally not required. Curettage or debridement was performed in a small minority of reported OMTB cases.[1] Surgery may be considered for extensive bone destruction, sequestrum removal, or failure to respond to medical therapy.[5][9]

Outcome and prognosis

Prognosis is excellent with appropriate anti-tubercular therapy. In the largest systematic review, only 5.2% of OMTB patients died of disease complications, while the remainder were alive at last follow-up.[1] Significant clinical and radiographic improvement is expected with standard treatment.[2] Treatment response is monitored clinically and radiographically, as bacteriologic follow-up specimens from the jaw are difficult to obtain.[5]